Instem Picks up BioWisdom for $2.4M to Expand Drug Development Data-Management Offerings
March 11, 2011
Instem Picks up BioWisdom for $2.4M to Expand Drug Development Data-Management Offerings
Instem, which is based in Staffordshire, UK, and employs just over 100 people worldwide, acquired the 13-person BioWisdom to add new information-extraction capabilities to its current drug development software tools.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- StarDrop Developers Acquire Software from BioFocus DPI, Launch New Firm
July 21, 2009 / BioInform - Persistent Buys Agilent's Software Marketing and Development Business; Eyes Expansion into Europe
June 3, 2011 / BioInform - Geschickten Expands Product Portfolio in Bid to Increase its Footprint
June 3, 2011 / BioInform - Life Biosystems Developing In Silico Toolkit for Personalizing Oncology Therapy
April 15, 2011 / BioInform - Accelrys to Tailor NGS Software for Oxford Nanopore Sequencer
March 18, 2011 / BioInform